greeksoup/ stock research

Interface Inc.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 7 August 2026: press release. Guidance figures: 3 raised, 3 new, 2 kept. The quarter’s numbers.

Key takeaways

  • Broad-based growth across regions and segments: Growth spanned all regions and product categories, reflecting strength of diversified portfolio and benefits of One Interface strategy for long-term positioning. Source
  • Healthcare billings outpace other segments: Healthcare delivered the strongest growth with global billings up 19%, while Education and Corporate Office billings each increased 5%, showing balanced portfolio expansion. Source
  • Gross margin expanded 524 basis points: Adjusted gross profit margin reached 45.0%, up 524 basis points. Operational improvements contributed 131 basis points while $15.6 million of IEEPA tariff refunds accounted for 393 basis points. Source
  • Pricing and manufacturing drove expansion: Higher sales volumes, proactive pricing actions, favorable product mix, and manufacturing efficiency initiatives created robust margin expansion without relying solely on cost reductions. Source
  • Robust backlog supports full-year guidance raise: Currency-neutral orders increased 5.4% in the quarter with AMS up 4.8% and EAAA up 6.4%, providing a robust backlog to sustain continued momentum through year-end. Source

Guidance

AreaPeriodFigureAgainst last quarter
Q3 2026 net sales Sourcethird quarter 2026$370 to $380 millionNew
Q3 2026 adjusted gross profit margin Sourcethird quarter 202640.8% of net salesNew
Q3 2026 adjusted SG&A expenses Sourcethird quarter 2026$100 millionNew
Full fiscal year 2026 net sales Sourcefull fiscal year 2026$1.455 to $1.485 billionRaised from $1.450 to $1.480 billion
Full fiscal year 2026 adjusted gross profit margin Sourcefull fiscal year 202640.6% of net salesRaised from 38.8% to 39.0% of net sales
Full fiscal year 2026 adjusted SG&A expenses Sourcefull fiscal year 2026$395 millionRaised from 26.2% to 26.4% of net sales
Full fiscal year 2026 adjusted interest and other expenses Sourcefull fiscal year 2026$15 millionKept
Full fiscal year 2026 adjusted effective income tax rate Sourcefull fiscal year 202626.0%Kept

What changed from last quarter

  • Guidance raised: Full year adjusted gross profit margin guidance raised to 40.6% from prior 38.8-39.0% range. Source

Results and Earnings Growth

  • Broad-based growth across regions and segments: Growth spanned all regions and product categories, reflecting strength of diversified portfolio and benefits of One Interface strategy for long-term positioning. Source

Segment and Market Performance

  • Healthcare billings outpace other segments: Healthcare delivered the strongest growth with global billings up 19%, while Education and Corporate Office billings each increased 5%, showing balanced portfolio expansion. Source

Margin Expansion Drivers

  • Gross margin expanded 524 basis points: Adjusted gross profit margin reached 45.0%, up 524 basis points. Operational improvements contributed 131 basis points while $15.6 million of IEEPA tariff refunds accounted for 393 basis points. Source
  • Pricing and manufacturing drove expansion: Higher sales volumes, proactive pricing actions, favorable product mix, and manufacturing efficiency initiatives created robust margin expansion without relying solely on cost reductions. Source
  • SG&A increased modestly on higher incentives: Adjusted SG&A expenses of $103.1 million rose $9.7 million year-over-year due to higher sales commissions and variable compensation on increased sales and profits, plus foreign exchange impacts. Source

Order Momentum and Backlog

  • Robust backlog supports full-year guidance raise: Currency-neutral orders increased 5.4% in the quarter with AMS up 4.8% and EAAA up 6.4%, providing a robust backlog to sustain continued momentum through year-end. Source

Balance Sheet and Capital Allocation

  • Debt levels and leverage remain moderate: Total debt of $204.4 million and net debt of $122.8 million represent net leverage of 0.5x adjusted EBITDA, providing financial flexibility and strong balance sheet foundation. Source

Coming up, per management

  • Third quarter 2026 sales expected $370-380 million: Q3 net sales guided to $370-380 million range with adjusted gross profit margin of 40.8% and SG&A expenses of $100 million. Source
  • Full-year momentum supported by backlog: Company expects continued execution of One Interface strategy with robust backlog supporting full-year guidance of $1.455-1.485 billion in sales and 40.6% adjusted gross margin. Source

Risks management discussed

  • External: Management acknowledged a dynamic and uncertain global macro environment as backdrop to guidance and future performance. Source
  • Financial: Substantial debt levels could adversely affect business, financial condition and ability to meet payment obligations. Source

Earlier plans management reported on

  • On track: Continued execution of One Interface strategy further strengthened company's competitive position according to management, with broad-based growth across segments confirming strategy effectiveness. Source
  • On track: Management raising full-year guidance based on strong first half performance and robust backlog supporting continued momentum through year-end. Source

Summarised with AI from the documents the company filed with the SEC. Every point carries a quote that is checked word for word against the filing; a point whose quote is not found is left out. Source opens the filing at that line.